ascopubs.org11d
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia We enrolled 16 patients ...
ascopubs.org5d
Addressing the Intersection of Chemotherapy-Induced Peripheral Neuropathy and Fall Risk in Cancer Survivors: Insights and Future Directions
Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion The following represents disclosure ...
ascopubs.org4d
Microsatellite Instability and Clinical Use in Sarcomas: Systematic Review and Illustrative Case Report
Sarcomas, a diverse group of malignancies, exhibit substantial heterogeneity in both biological behavior and microenvironment, influencing their response to immunotherapy. Although pembrolizumab is ...
ascopubs.org10d
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial At the time of data lock, 204 ...
ascopubs.org3d
Counting the days: Exploring healthcare contact days during episodes of cancer care.
*Ambulatory visits days are not mutually exclusive. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a full text component.
ascopubs.org27d
Clinical utility of upfront liquid biopsy in non-small cell lung cancer in the community setting.
Improving vaccination counseling rates in first time patients with cancer: A multi-disciplinary approach. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does ...
ascopubs.org25d
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members In this multicenter phase I ...
ascopubs.org23d
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org10d
Development and Validation of a Clinical Prediction Model for Paclitaxel Hypersensitivity Reaction on the Basis of Real-World Data: Pac-HSR Score
Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in Brazil This study involved 3,708 patients with ...
ascopubs.org10d
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral
Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas ...
ascopubs.org6d
Reply to E. Shash
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...